Pharmacokinetics of cytisine after single intravenous and oral administration in rabbits

Interdisciplinary Toxicology

Volumn 3, Issue 1, 2010, Pages 15-20

  Astroug, Henri ^a   Simeonova, Roumiana ^a   Kassabova, Lilia ^b   Danchev, Nikolay ^a   Svinarov, Dobrin ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

cytisine; HPLC method; pharmacokinetics; rabbits

Indexed keywords

CYTISINE;

ANIMAL EXPERIMENT; APTITUDE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PHARMACOKINETICS; QUANTITATIVE ANALYSIS; RABBIT; SINGLE DRUG DOSE; ULTRAVIOLET RADIATION;

ORYCTOLAGUS CUNICULUS;

EID: 77956244152     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-010-0003-5     Document Type: Article

References (11)

1. Bioanalytical method validation. (2001). Guidance for industry. FDA/CDER/CVM/DHHS.
2. Coe J, Brooks P, Vetelino M, Wirtz M, Arnold E, Huang J, Sands S, Davis T, Lebel L, Fox C, Shrinkhande A, Heym J, Schaef er E, Rollema H, Lu Y, Mansbach R, Chambers L, Rovetti C, and Schulz D. (2005). Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48: 3474-3477.
3. Dobreva D, Danchev N, Nikolova I. (2005). Tabex-Sopharma-natural alternative for smoking cessation and treatment of nicotine dependence. Pharmacia 52: 30-35.
4. Gonzales D, Rennard S, Nides M, Oncken C, Azoulay S, Billing C, Watsky E, Gong J, Williams K and Reeves K. (2006). Varenicline, an alpha4beta2 nicotinic acetylo-choline receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation. A randomized controlled trial. JAMA 296: 47-55.
5. Imming P, Klaperski P, Stubbs M, Seitz G and Gündisch D. (2001). Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands. Eur J Med Chem 36: 375-388.
6. 2-nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation. A randomized controlled trial. JAMA 296: 56-63.
7. 3H-cytisine. Arch Toxicol Suppl 4: 312-314.
8. Lickint F. (1956). Medikamentöse Unterstützung der Tabakenwöhnung. Thera-piewoche 6: 444-448.
9. Mokdad A, Marks J, Stroup D and Gerberding J. (2004). Actual causes of death in the United States. JAMA 291: 12 3 8-1245.
10. Sariev?, V Zherdev V, Sologova S, Litvin A, Rodionov A, Kolyvanov G and Vasilev A. (1999). Cytisine pharmacokinetics when used in a transdermal therapeutic system in rabbits. Exp Clin Pharmacol 62: 59-61.
11. Tonstad S, Tønnesen P, Hajek P, Williams K, Billing C and Reeves K. (2006). Effect of maintenance therapy with varenicline on smoking cessation. A randomized controlled trial. JAMA 296: 64-71.